Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Willis Towers Q1 Earnings Miss Estimates, Revenues Decline Y/Y

In This Article:

Willis Towers Watson Public Limited Company WTW delivered first-quarter 2025 adjusted earnings of $3.13 per share, which missed the Zacks Consensus Estimate by 2.1%. The bottom line remained flat year over year.

The insurer’s results reflect higher revenues and expanded operating margins at the Risk & Broking segment, as well as lower expenses. It was offset by lower revenues at the Health, Wealth & Career segment and reduced adjusted operating income. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)

Willis Towers’ Operational Update

Willis Towers posted adjusted consolidated revenues of $2.2 billion, down 5% year over year on a reported basis, due to the sale of TRANZACT. Revenues increased 5% on an organic basis and decreased 4% on a constant currency basis. The top line missed the Zacks Consensus Estimate by 3.9%.

The total costs of providing services decreased 13% year over year to $1.8 billion due to lower salaries and benefits, other operating expenses, depreciation, amortization, restructuring costs, transaction and transformation. The figure was lower than our estimate of $2 billion. 

Adjusted operating income was $480 million, down 1% year over year. Adjusted operating margin expanded 100 basis points (bps) to 21.6%.

Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise

Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise
Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise

Willis Towers Watson Public Limited Company price-consensus-eps-surprise-chart | Willis Towers Watson Public Limited Company Quote

Adjusted EBITDA was $532 million, down 3% year over year. Adjusted EBITDA margin was 23.9%, which expanded 60 bps.

Quarterly Segment Update of Willis Towers

Health, Wealth & Career: Total revenues of $1.1 billion fell 13% year over year (12% decrease on a constant currency and 3% decline on an organic basis). Our estimate was pegged at $1.2 billion.

Health delivered organic revenue growth in all regions, driven by solid client retention, new business and geographic expansion. 
Wealth generated organic revenue growth from higher levels of Retirement work in Europe and International, alongside growth in the Investments business due to the success of the LifeSight solution and capital market improvements. 

Career had modest revenue growth as increased advisory work was tempered by some postponements amid economic uncertainty. 
Benefits Delivery & Outsourcing revenues grew primarily from increased project and core administration work.

The operating margin was 26.7%, which increased 160 bps from the prior-year quarter, primarily due to the sale of TRANZACT and savings from the Transformation program.

Risk & Broking: Total revenues of $1.03 billion rose 5% year over year (7% increase in constant currency and on an organic basis). The figure matched our estimate.

Corporate Risk & Broking had organic revenue growth, driven by higher levels of new business activity and strong client retention globally. 
Insurance Consulting and Technology had organic revenue growth, driven by the Consulting and Technology practices. 

The operating margin increased 120 bps from the prior-year quarter to 22%, primarily due to operating leverage driven by strong organic revenue growth and savings from the Transformation program. It was partially offset by headwinds from decreased interest income and foreign currency fluctuations.